Apart from these common mutations, many genes had intermediate mutation frequencies in RMM, including BARD1, SPTA1, MGA, and BCR. These genes are associated with the occurrence of other malignancies, but have not been reported in MM, indicating that the potential therapeutic targets for RMM needs to be further studied. The gene discussed is MGA; the disease is Miyoshi myopathy.